# The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

> **NCT05904951** · — · COMPLETED · sponsor: **Alvimedica** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Disease
- Vascular Diseases

## Interventions

- **DEVICE:** INVADER™ PTCA Balloon Dilatation Catheter

## Key facts

- **NCT ID:** NCT05904951
- **Lead sponsor:** Alvimedica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05904951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05904951, "The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05904951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*